HEU-EFS Mid-Term Virtual Consortium Meeting Marks Key Milestone in Year 3

On 16 April 2026, the HEU-EFS consortium gathered online for its Mid-Term Virtual Consortium Meeting, bringing together project partners to reflect on progress achieved so far and align on priorities for the next phase of the project.

The meeting marked an important milestone in Year 3 of HEU-EFS and provided a valuable platform for collaboration, strategic discussion, and knowledge exchange across the consortium.

Reviewing Progress and Shaping the Next Phase

Throughout the meeting, partners reviewed achievements across multiple Work Packages (WP2–WP9), highlighting the progress made toward advancing a harmonised European framework for Early Feasibility Studies (EFS) in medical devices.

Key discussions focused on:

• Project progress and overall impact achieved to date
• Developments in the evolving EU regulatory landscape
• Newly established Task Forces related to MDR revision, Digital Health Technologies, and R&D incentives
• Pilot use cases and engagement with National Competent Authorities
• Dissemination activities, project management updates, and upcoming milestones

The consortium also discussed future priorities and preparations for upcoming meetings, including the Annual Consortium Meeting scheduled to take place in Oslo in July 2026.

Strengthening Collaboration Across Europe

The meeting demonstrated the continued strength of collaboration across the HEU-EFS consortium, with partners contributing expertise from regulatory, clinical, academic, industry, and public health perspectives.

We would like to sincerely thank all consortium partners for their valuable contributions, active engagement, and continued commitment to the project’s objectives.